A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma

Clinical trial NCT02157636 · COMPLETED

Trial details

NCT number: NCT02157636
Sponsor: Constellation Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2014-07-15
Primary completion: 2016-11-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.